# Curaleaf Challenges Aurora Board Over Rejection of Takeover Proposal

- URL: https://stocks.freetheai.org/news/curaleaf-challenges-aurora-board-over-rejection-of-takeover-proposal-15dd65
- Published: 2026-10-19T11:15:00Z
- Category: mergers; sentiment: bearish; impact: medium
- Symbols: [TSX:CURA](https://stocks.freetheai.org/symbols/TSX-CURA)
- Written by our AI from expert market sources across the web for FreeTheAI Stocks, built by Vibhek Soni
- How write-ups are made: https://stocks.freetheai.org/how-we-write
- Not financial advice: https://stocks.freetheai.org/disclaimer

Curaleaf Holdings, Inc. (TSX:CURA) has publicly criticized Aurora Cannabis Inc. after Aurora's board urged shareholders to reject Curaleaf's enhanced takeover proposal. Curaleaf voiced frustration over being denied due diligence access, even as Aurora signed standstill agreements and granted financial access to other prospective suitors.

The takeover dispute revolves around valuation and board engagement. Curaleaf noted its revised offer reflects an 86% premium to Aurora's 30-day average share price, rising to 217% on an ex-cash basis. Curaleaf also pointed out that Aurora sold equity as low as $2.60 per share in July 2026 under its ATM program, making the $5.00 offer price a 92% premium over those sales.

Market participants will watch to see if Aurora's board enters discussions with Curaleaf or if rival proposals emerge from other firms examining its financial records. Curaleaf Holdings, Inc. (TSX:CURA) stock fell 6.90% to 11.07 CAD during today's trading session.

## Key points

- Curaleaf Holdings, Inc. (TSX:CURA) challenged Aurora Cannabis Inc. for blocking its due diligence requests while permitting other bidders access.
- Curaleaf stated its enhanced takeover proposal offers an 86% premium over Aurora's 30-day average share price, or 217% on an ex-cash basis.
- Aurora's board previously issued a Notice of Change recommending shareholders reject Curaleaf's revised acquisition offer.
- Curaleaf highlighted Aurora selling shares as low as $2.60 in July 2026 to argue its $5.00 proposal offers fair value.
- Shares of Curaleaf Holdings, Inc. (TSX:CURA) fell 6.90% to 11.07 CAD.

## Questions and answers

### Why did Curaleaf criticize Aurora's board?

Curaleaf stated Aurora's board unfairly denied it due diligence access while granting access to undisclosed third parties and recommending shareholders reject Curaleaf's enhanced takeover proposal.

### What are the key terms of Curaleaf's offer for Aurora?

Curaleaf's enhanced bid offers an 86% premium over Aurora's 30-day average share price and a 217% premium ex-cash, significantly above Aurora's July 2026 share sales of $2.60.

### How did Curaleaf stock move following the announcement?

Curaleaf Holdings, Inc. (TSX:CURA) stock dropped 6.90% to 11.07 CAD.